Sleep lab better than home testing for apnoea:
This article was originally published in Clinica
Executive Summary
Investigation of obstructive sleep apnoea syndrome in a sleep laboratory is associated with a better outcome than recording cardiorespiratory variables at home, a US computer modelling study has found. Reporting their findings in the March issue of Annals of Internal Medicine, Dr Ronald Chervin and colleagues say that under almost all the situations investigated in the study, laboratory-based polysomnography provided maximal quality-adjusted life-years in the five years immediately after the initial diagnostic evaluation. However, an editorial in the same journal criticises the study for including only one type of home testing device and for assuming that all patients need to undergo the same diagnostic tests.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.